CLTS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLTS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Earth Life Sciences's Enterprise Value is $0.67 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Therefore, Earth Life Sciences's EV-to-EBIT for today is -1.91.
The historical rank and industry rank for Earth Life Sciences's EV-to-EBIT or its related term are showing as below:
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -5.16%.
The historical data trend for Earth Life Sciences's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Life Sciences Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
EV-to-EBIT | Get a 7-Day Free Trial | -139.73 | -7.67 | -66.84 | -3.36 | -4.12 |
Earth Life Sciences Quarterly Data | ||||||||||||||||||||
Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Jun22 | Sep22 | |
EV-to-EBIT | Get a 7-Day Free Trial | -3.56 | -6.79 | -4.12 | -30.73 | -19.39 |
For the Information Technology Services subindustry, Earth Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Software industry and Technology sector, Earth Life Sciences's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Earth Life Sciences's EV-to-EBIT falls into.
Earth Life Sciences's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 0.668 | / | -0.349 | |
= | -1.91 |
Earth Life Sciences's current Enterprise Value is $0.67 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Life Sciences (OTCPK:CLTS) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2022 ) |
= | -0.349 | / | 6.767298 | |
= | -5.16 % |
Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Earth Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
John Farinaccio | director, officer: Vice President | 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7 |
Jocelyn Moisan | director, officer: Predident | 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7 |
George Tsolakos | officer: VP Business Development | 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7 |
Angelo M Marino | director, officer: Secretary and Vice President | 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7 |
Uwd Unitas World Development Inc. | 10 percent owner | 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7 |
Greg A Thompson | director | 11123 TUPPER LAKE DRIVE, HOUSTON TX 77042 |
Darrell Parlee | officer: Treasurer | 2144 CROWBRIDGE DRIVE, FRISCO TX 75034 |
Andy Kim | director | 1408 STONE CUTTER DR., OAKVILLE A1 00000 |
Steve Bajic | officer: Secretary | 918-1030 WEST GEORGIA STREET, VANCOUVER A1 V6E 2Y3 |
Donald L Sytsma | director, officer: CFO and Treasurer | 2404 ECHO HARBOR DRIVE, PEARLAND TX 77584 |
Bassam Nastat | director | 5631 WINCH ST, BURNABY BC A1 V5B 2J4 |
Milton Cox | director, officer: President | 7227 WINCHESTER RD #258, MEMPHIS TN 38118 |
Michael P Twyman | director, 10 percent owner, officer: President | |
Andrew B Stewart | director, 10 percent owner, officer: Secretary | 1208 1030 W GEORGIA ST, VANCOUVER BC A1 9999999999 |
From GuruFocus
By Marketwired Marketwired • 12-18-2018
By PRNewswire PRNewswire • 08-11-2022
By PRNewswire PRNewswire • 06-06-2018
By Marketwired Marketwired • 01-06-2020
By ACCESSWIRE ACCESSWIRE • 06-28-2022
By Marketwired Marketwired • 01-22-2019
By Marketwired Marketwired • 12-16-2019
By ACCESSWIRE ACCESSWIRE • 10-06-2021
By Marketwired Marketwired • 01-16-2019
By Marketwired Marketwired • 01-08-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.